Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?

Gönczi Lóránt, Végh Zsuzsanna, Golovics Petra Anna, Rutka Mariann, Gecse Krisztina Barbara, Bor Renáta, Farkas Klaudia, Szamosi Tamás, Bene László, Gasztonyi Beáta, Kristóf Tünde, Lakatos László, Miheller Pál, Palatka Károly, Papp Mária, Patai Árpád, Salamon Ágnes, Tóth Gábor Tamás, Vincze Áron, Bíró Edina, Lovász Barbara Dorottya, Kürti Zsuzsanna, Szepes Zoltán, Molnár Tamás, Lakatos Péter László: Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?
JOURNAL OF CROHNS & COLITIS, (11) 6. pp. 697-705. ISSN 1873-9946 (2017)

[img] Text
3140312_Gonczi.pdf - Published Version
Korlátozott. Registered users only

Download (312kB) | Request a copy
Item Type: Article
Journal or Publication Title: JOURNAL OF CROHNS & COLITIS
Date: 2017
Volume: 11
Number: 6
Page Range: pp. 697-705
ISSN: 1873-9946
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
SWORD language: Angol
Identification Number: 3140312
DOI id: https://doi.org/10.1093/ecco-jcc/jjw203
Date Deposited: 2017. Sep. 28. 13:04
Last Modified: 2017. Sep. 28. 13:04
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12011

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year